Robert Martin Emanuele, V P, Business Development at AVANIR PHARMACEUTICALS (AVNR), bought 1,000 shares at $8.99 ($9K) on 2006-05-25, disclosed to the SEC on 2006-05-25.
Open-market purchase of $9k AVNR by V P, Business Development. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.